A. Tavakolpournegari

Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.

A. Zarrabi, M. Hashemi, N. Nabavi, 2022, International journal of biological macromolecules.

Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation

A. Aref, F. Ghadyani, M. Entezari, 2022, Journal of Drug Delivery Science and Technology.

Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents.

A. Zarrabi, M. Hashemi, N. Nabavi, 2022, Pharmacological research.

Crosstalk of miRNAs With Signaling Networks in Bladder Cancer Progression: Therapeutic, Diagnostic and Prognostic Functions.

M. Hashemi, M. Entezari, Hamidreza Saebfar, 2022, Pharmacological research.

Effects of true-to-life PET nanoplastics using primary human nasal epithelial cells.

R. Marcos, Aliro Villacorta, Balasubramanyam Annangi, 2023, Environmental toxicology and pharmacology.

Harmful effects of true-to-life nanoplastics derived from PET water bottles in human alveolar macrophages.

S. Pastor, Balasubramanyam Annangi, Alireza Tavakolpournegari, 2024, Environmental pollution.

EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions.

M. Hashemi, K. Hushmandi, M. Entezari, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Teabag-derived micro/nanoplastics (true-to-life MNPLs) as a surrogate for real-life exposure scenarios.

A. García-Rodríguez, Doaa Abass, G. Banaei, 2024, Chemosphere.

Hazard assessment of nanoplastics is driven by their surface-functionalization. Effects in human-derived primary endothelial cells.

A. García-Rodríguez, A. Villacorta, G. Banaei, 2024, The Science of the total environment.